1. CT Fluoroscopy-Guided Percutaneous Gastrostomy in the Palliative Management of Advanced and Relapsed Ovarian Cancer: The Charité Experiences and a Review of the Literature.
- Author
-
Canaz, Emel, Sehouli, Jalid, Gebauer, Bernhard, Segger, Laura, Collettini, Federico, and Auer, Timo Alexander
- Subjects
- *
BOWEL obstructions , *OVARIAN tumors , *PERITONEAL cancer , *MINIMALLY invasive procedures , *RETROSPECTIVE studies , *FLUOROSCOPY , *TREATMENT effectiveness , *QUALITY of life , *DESCRIPTIVE statistics , *GASTROSTOMY , *COMPUTED tomography , *TRANSILLUMINATION , *PALLIATIVE treatment , *DISEASE complications - Abstract
Simple Summary: Malignant bowel obstruction (MBO) requires adequate palliation in progressive ovarian cancer. Percutaneous endoscopic gastrostomy has limitations in 32.7% of patients with advanced/recurrent ovarian cancer due to anatomical constraints and a lack of transillumination. CT-guided gastrostomy is a safe and effective procedure, enabling rapid recognition of the anatomy, particularly in complex patients with peritoneal carcinomatosis and previous multivisceral surgeries. This technique should be particularly emphasized within the palliative management of MBO. A clinical registry should be implemented to evaluate the effectiveness of various treatment strategies in MBOs associated with gynaecological cancers. Peritoneal carcinomatosis-associated malignant bowel obstruction is a common feature that merits more attention in advanced and recurrent ovarian cancer. Decompressive gastrostomy is one of the most preferred methods to palliate distressing symptoms and maintain patients' quality of life. We retrospectively identified 31 patients with ovarian cancer-associated MBO, who underwent decompressive CT fluoroscopy-guided percutaneous gastrostomy (CT-PG) between September 2015 and April 2023 at our institution. A systematic literature review was conducted for CT-guided gastrostomy in ovarian cancer. Prior to CT-PG, 27 (87%) patients underwent unsuccessful attempts at endoscopic gastrostomy or surgery due to bowel obstruction; a total of 55% had received ≥3 lines of chemotherapy. CT-PG could be successfully inserted in 25 of 31 (81%) patients without grade 4–5 complications. CT-PG insertion was feasible in 76% of patients with previous unsuccessful attempts of endoscopic gastrostomy. A total of 80% of patients with a successful insertion had considerable symptom relief and could tolerate fluid intake. Mean survival after the procedure was 44.4 days. Chemotherapy could be administered in 7 of 25 (28%) patients following the CT-PG insertion. CT-guided percutaneous gastrostomy is a safe procedure that effectively manages intractable symptoms of bowel obstruction in ovarian cancer. This minimally invasive technique should be emphasised as a routine instrument within the palliative management of MBO. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF